ICIS is implementing a process of rolling consultation on all of its pricing methodologies. This consultation paper is part of this formal process and covers all of the ICIS primary price points included in the butadiene weekly publications.
The consultation asks both general questions about the suitability of the ICIS pricing methodology and questions addressing specific butadiene market issues.
Click here to view the Butadiene Methodology Consultation 2023 – GMC0423
Summary and Decision
The consultation asked general questions about the suitability of the ICIS pricing methodology. ICIS received no formal responses on this consultation and as a result will not propose any immediate changes to the butadiene methodology. Any decision to change this methodology will be communicated to subscribers using the usual channels and with the usual notice period.
ICIS continues to welcome any feedback on its butadiene methodology outside of the formal consultation process.
To provide further comments or feedback please contact William Lemos, Deputy Editorial Director: William.Lemos@icis.com
